Company / FCF Margin
LivaNova FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
12.5%
FY2025
5-year range
-12.3% / 12.5%
FY2021-FY2025
Trend
+15.1%
vs FY2024
Sector context
#43 of 145
Health Care
What the data says
At 12.5%, LivaNova's fcf margin ranks #43 of 145 in the Health Care sector. FCF Margin has increased for 3 consecutive years, from -12.3% in FY2022 to 12.5% in FY2025.
Based on SEC 10-K filings.
12.5% in FY2025 with a 5-year CAGR of +24.7%.
Improved from 3.5% to 12.5% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +24.7pp
- 5-Year Change
- +24.7pp
- 10-Year Change
- -
Sector benchmark
#43 of 145 in Health CareTop 30% of 145This company 12.5% Sector average -207.5%
▼
+106.0% above sector average
Key checks
Key Insights
- LivaNova's fcf margin has grown for 3 consecutive years.
- In FY2025, fcf margin increased 15.1% year-over-year.
- Currently 220.0pp above the Health Care sector average.
- Lowest fcf margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 12.5% | +15.1% |
| FY2024 | 10.8% | +213.3% |
| FY2023 | 3.5% | +128.2% |
| FY2022 | -12.3% | -14.7% |
| FY2021 | -10.7% | +12.8% |
| FY2020 | -12.3% | -14.7% |
| FY2019 | -10.7% | -241.8% |
| FY2018 | 7.5% | +30.5% |
| FY2017 | 5.8% | +7.4% |
| FY2016 | 5.4% | +173.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026